Man patients with MIBC are ineligible for or refuse SOC cisplatin. SunRISe-4 evaluated neoadjuvant gemcitabine intravesical system (TAR-200) plus cetrelimab or cetrelimab monotherapy for pathologic ...
The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year.
Overall survival is no better for patients diagnosed with NMIBC who progress directly to metastasis.
If you have metastatic bladder cancer, you may also be at higher risk for kidney problems, including acute kidney injuries ...
Discover a comprehensive palliative care plan designed to enhance quality of life for those with metastatic bladder cancer.